rs67939655
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 4P and 5B. PM1PM5BP6BS2
The NM_000531.6(OTC):c.140A>C(p.Asn47Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000141 in 1,198,077 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 55 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N47H) has been classified as Uncertain significance.
Frequency
Consequence
NM_000531.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OTC | NM_000531.6 | c.140A>C | p.Asn47Thr | missense_variant | 2/10 | ENST00000039007.5 | |
OTC | NM_001407092.1 | c.140A>C | p.Asn47Thr | missense_variant | 4/12 | ||
OTC | XM_017029556.2 | c.140A>C | p.Asn47Thr | missense_variant | 2/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OTC | ENST00000039007.5 | c.140A>C | p.Asn47Thr | missense_variant | 2/10 | 1 | NM_000531.6 | P1 | |
OTC | ENST00000488812.1 | n.232A>C | non_coding_transcript_exon_variant | 2/6 | 5 | ||||
OTC | ENST00000643344.1 | c.140A>C | p.Asn47Thr | missense_variant, NMD_transcript_variant | 2/11 |
Frequencies
GnomAD3 genomes ? AF: 0.000108 AC: 12AN: 111423Hom.: 0 Cov.: 22 AF XY: 0.0000595 AC XY: 2AN XY: 33589
GnomAD3 exomes AF: 0.000158 AC: 29AN: 183170Hom.: 0 AF XY: 0.000192 AC XY: 13AN XY: 67772
GnomAD4 exome AF: 0.000144 AC: 157AN: 1086654Hom.: 0 Cov.: 27 AF XY: 0.000150 AC XY: 53AN XY: 352460
GnomAD4 genome ? AF: 0.000108 AC: 12AN: 111423Hom.: 0 Cov.: 22 AF XY: 0.0000595 AC XY: 2AN XY: 33589
ClinVar
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Uncertain:3Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 19, 2024 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 25, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Uncertain significance, no assertion criteria provided | research | CSER _CC_NCGL, University of Washington | Jun 01, 2014 | - - |
not provided Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | GenMed Metabolism Lab | - | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 11, 2020 | The p.Asn47Thr variant in OTC is classified as likely benign because although it has been reported in 1 female with ornithine transcarbamylase (OTC) deficiency (PMID 16786505), it has also been identified in 14/75447 hemizygous males in gnomAD (http://gnomad.broadinstitute.org), which is an allele frequency too high to cause OTC deficiency. ACMG/AMP criteria applied:BS1, BS4. - |
OTC-related condition Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 10, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at